| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 695267 | Null | 0.00366577979610627 | 0.3154281 |
| NSC 702378 | Null | 0.00366577979610627 | 0.19668869 |
| NSC 705437 | Null | 0.00366577979610627 | 0.37066306 |
| NSC 710546 | Null | 0.00366577979610627 | 0.12508596 |
| NSC 740353 | Null | 0.00407837248037199 | 0.43606028 |
| NSC 743430 | 2-{4-[4-(4-{4-[6-(4-methyl piperazino)-1H-benzo[d]imidazole-2-yl]phenoxy}butyl)piperazino]butyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione | 0.00407837248037199 | 0.17581078 |
| NSC 748264 | Null | 0.00407837248037199 | 0.353923 |
| NSC 750148 | 3-(2-Hydroxy-5-chloro-4-methylphenyl)-5-(2-phenylethene)-1-(4-sulfamylphenyl)-pyrazoline | 0.00407837248037199 | -0.25448543 |
| NSC 761676 | Null | 0.00407837248037199 | 0.31192196 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.00407837248037205 | 0.29443472 |